Clinical Pharmacy Research Grant
GUIDANCE NOTES & APPLICATION FORM
After completion this form should be returned to:
Pharmacy Research UK
66-68 East Smithfield,
London E1W 1AW
Pharmacy Research UK
66-68 East Smithfield
London
E1W 1AW
Registered Charity: 1148335
www.pharmacyresearchuk.org
UKCPA
1st Floor, Publicity House
59 Long Street
Wigston
Leicestershire LE18 2AJ
www.ukcpa.org
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
GUIDANCE NOTES
The UKCPA-Pharmacy Research UK Clinical Pharmacy Research Grant is aimed at pharmacists wishing
to conduct a clinical pharmacy research project in the UK. The focus of this grant is to support pharmacy
practitioners who wish to develop their research skills and in doing so build relationships with the
academic community, attend formal training programmes and seek mentors.
Applications will be assessed and shortlisted through a process of expert peer review. Shortlisted
applicants will be invited to interview to discuss their application, which will include a 15-minute
presentation from the lead applicant, followed by 20 minutes of questions from a Review Panel.
Funding decisions will be made at the end of the day after all the interviews are completed. At this point
the panel will also consider possible mentors for the applicants who will then be approached by
Pharmacy Research UK. Applicants will be notified by email within five working days following the
interview. All applicants (including those not shortlisted) will be provided with feedback on their
application.
Applications are assessed by the Panel using the following criteria:
When assessing the applicant and their team
 The quality and relevance of the applicant’s recent and overall clinical experience
 While the intention of this grant is to support novice researchers to develop research capacity
and capability, it is important that the applicant has identified appropriate experienced
researchers (either as co-lead applicants, co-investigators, collaborators, mentors, advisors, or
supervisors) to enhance study design, delivery and dissemination, while supporting the
applicant’s research development.
 The evidenced commitment and potential of the applicant to develop their research skills
alongside their clinical practice.
 The range of knowledge, skills and expertise on the team to deliver the proposed study
When assessing the research proposal
 The extent to which the Grant will support the development of the individual’s research skills
 The extent to which the Grant will support the development of partnerships and relationships
between clinical practitioners and the academic community
 The extent to which the Grant will support a small pilot, feasibility study or systematic review
which has the potential to be developed into a larger study for future funding
 The quality of the proposed study and its potential to benefit patients and/or clinical practice in
the longer term
 The extent to which the Grant will support the applicant to attend formal training programmes
in order to develop research skills
When assessing the proposed costs
 The appropriateness of resources claimed and whether the total funding requested represents
good value for the use of the funds.
To be considered for funding the project must:


Have a Lead Applicant who is a current UKCPA member and Royal Pharmaceutical Society member
Apply directly to the definition of pharmaceutical care as described by Hepler & Strand (1990): "The
responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a
patient's quality of life.”
1
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015







Be aligned with the UKCPA mission statement and vision (see here: www.ukcpa.net/about/mission)
and Pharmacy Research UK’s vision and purpose (see here:
http://www.pharmacyresearchuk.org/about-us/our-story/)
Have a clear research question or hypothesis
Have robust methodology
Have clear, defined and measurable outcomes
Be completed within 12 months (unless under exceptional circumstances such as significant delays
outside the control of the project team)
Be conducted in the UK
Request no more than £20,000*
If the application is successful the Lead Applicant is required to:







Provide a verbal report to Pharmacy Research UK and UKCPA representatives four months into the
project.
Submit a written progress report at eight months into the project (with reference to project
milestones stated in the Application Form).
Submit a written final report at the conclusion of the project (12 months).
Report the progress as a poster presentation at the UKCPA conference during the lifetime of the
project.
Submit a Research Proposal Summary (see Section 9) to be uploaded to the UKCPA and Pharmacy
Research UK websites upon notification of the success of the application.
Submit a précis of the project results to be uploaded to the UKCPA and Pharmacy Research UK
websites on completion of the project
Acknowledge UKCPA and Pharmacy Research UK in all presentations and publications related to the
funded project.
All applications for funding should be made on this application form by the Lead Applicant. It is in the
applicant’s own interest to provide the information requested in the application form in the manner
requested and as fully and clearly as possible.
Failure to complete any required section of the application form or to provide any requested
accompanying information will result in the application being delayed or rejected.
To enable us to process and review your application, please also complete and sign the checklist below
before returning to:
Clinical Pharmacy Research Grant
Pharmacy Research UK
66-68 East Smithfield
London E1W 1AW
Practice.Research@rpharms.com
DEADLINE FOR APPLICATIONS: 5pm, 4h May 2016
2
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
CHECKLIST
I confirm that I, the lead applicant:









Am a member of UKCPA. My membership number is ……………………………………..
Am a member of the Royal Pharmaceutical Society. My membership number is …………………………….
Have completed all sections of this Application Form
Have included brief CVs of all applicants
Have obtained all necessary supporting signatures in Section 7 (Declarations)
Have included signed letters of support from any relevant supporting organisation, for example,
patient or pharmacy organisation
Have included a cover letter
Have included two hard copies of the application form
Have emailed this Application Form and any supplementary documents to:
Clinical Pharmacy Research Grant
Pharmacy Research UK
66-68 East Smithfield
London E1W 1AW
Practice.Research@rpharms.com
Declaration:
I confirm that, should the application be successful, any completed fields that were stated as being
publishable in this application may be used for publication on the UKCPA and Pharmacy Research UK
websites.
Furthermore, I have fully disclosed any potential competing interests1 within the covering letter.
Signature of Lead Applicant
1
Date
A competing interest is anything that interferes with, or could reasonably be perceived as
interfering with, the objectivity of the research. Competing interests can be financial or nonfinancial, professional, or personal. Competing interests can arise in relationship to an organisation
or another person.
3
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 1: RESEARCH PROPOSAL OUTLINE
Please complete this section for all applicants. Contact details for the lead applicant should be for the
location where the lead applicant spends the majority of their time.
“Other applicants” are co-investigators who will provide significant intellectual input into the research
and will be responsible for day-to-day running of some aspects of the work.
Please ensure that the proposed start date of your study is realistic. For example, you may need to
factor in time for research contract negotiation and research staff recruitment.
SECTION 2: TECHNICAL SUMMARY OF THE PROPOSAL
Please provide a clear summary of the proposed research under the following headings:
1.
2.
3.
4.
Background
Aims and objectives
Methods
How the results of the research will be used
Please note, if your application is successful this summary will be published on the UKCPA and Pharmacy
Research UK websites and will be used for public information.
Maximum 500 words.
SECTION 3: LAY SUMMARY OF THE PROPOSAL
Please describe the aim of the research, how it will be carried out, how the findings will be used
following completion of the project, and its relevance to practice and public benefit. Please use plain
English, avoid the use of jargon and explain any technical terms included. This summary will be used for
communications with the public, should the application be successful, including any lay representatives
involved in the peer review process.
Maximum 500 words.
SECTION 4: DETAILS OF THE RESEARCH PROPOSAL
Please complete the whole of this section. Suggested maximum word counts are provided.
A
Aims and objectives (200 words)
B
Relevance to UKCPA vision and Pharmacy Research UK vision and purpose (500 words)
Please describe here how the project fits within the overarching vision, mission statement,
objectives and strategic direction of UKCPA, and the vision and purpose of Pharmacy Research UK.
UKCPA Vision & Mission: www.ukcpa.net/about/mission
Pharmacy Research UK Vision & Purpose: http://www.pharmacyresearchuk.org/about-us/ourstory/)
C
Benefits of the proposed research (800 words)
Please describe here how the project will benefit patients/public and pharmacy practice.
4
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
D
Background (1500 words)
This should address the following points:
1. What is the problem to be addressed (supported with figures to indicate scope of the problem
nationally)?
2. What are the principal research questions to be addressed?
3. Why is a study needed now (supported with published evidence, professional and consumer
consensus and pilot studies, where available)?
4. Describe how the research will differ from or complement any relevant planned, ongoing or
recently completed research elsewhere in the UK or internationally.
5. How will the results of this study be used?
E
Plan of investigation (1750 words)
Please cover the following, where relevant:
1. Study design and delivery (including designs you have rejected during the development stages,
if appropriate)
2. Sample size, if appropriate
3. Statistical design, if appropriate
4. Justification of chosen methods
We strongly advise study teams to contact their local Research Design Service in the development
of their application.
F
List of outputs/deliverables and plans for dissemination (500 words)
Please provide details of planned outputs, for example, full report and executive summary,
conference abstracts and journal papers. Please also include any planned dissemination or
engagement activity with key stakeholder groups, including patients and the public.
G
Study management (800 words)
Please cover the following:
1. What are the arrangements for day-to-day management (data handling, coordination etc)?
2. What will be the responsibilities of the applicants (experience, expertise, role and time
commitment)? We strongly encourage applicants to partner with academia (as co-investigators)
in order to strengthen the research expertise within the project team and to provide
mentorship and advice to the novice applicant. Please provide CVs of all applicants which
outline any previous relevant clinical and/or research experience.
3. Are there named collaborators (people/organisations) on this project – if so, what is their role
and contribution? Please list collaborators contributing to the proposed research and attach a
signed original letter, or email stating their willingness to participate in the project.
4. Does the study have an advisory committee (we recommend this as good practice)? If so please
provide details of the committee members and their role.
5. Patient and Public Involvement (PPI) – PPI is strongly encouraged at all stages of research design
and delivery. Applicants should describe any actual or planned PPI in this section.
5
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
H
Development of research skills (500 words)
Please provide details of how the grant will contribute to the development of the applicant’s
research skills. Please also give details of any formal or informal research training and mentorship
you propose to undertake as part of the grant. If possible please indicate where this will take place
and the associated cost.
I
Project Timetable (500 words)
Please provide an estimated timeline for project deliverables, including an estimated start date,
and risks of delays such as ethics approval processes and recruitment.
If your application is successful, the progress of the project will be monitored against these stated
milestones, and funding may be withheld if progress is not satisfactory (unless under exceptional
circumstances such as significant delays outside of the control of the project team, for example,
process for ethics approval).
A Gantt chart illustrating the project timetable and dependencies between activities is the
preferred presentation format here.
J
Measures of success (500 words)
As well as the outputs (results of research) applicants should describe here the possible study
outcomes (measurable steps that make use of the research outputs) and potential impact
(measurable change – based on outputs and outcomes).
Provide details of the measurable outcomes used to evaluate the success of the project and how
the quality of the project and its outcomes will be monitored.
K Future plans (500 words)
Applicants are encouraged to consider how the study will lead to further developments in the area.
For example, if the study is a systematic review of evidence, how will this inform practice or future
research? If the study is a pilot or feasibility study, how will this contribute to a larger study?
L
Stakeholders (200-500 words)
Stakeholders are the individuals or groups who could impact positively or negatively on the success
of the project, by virtue of their role or influence. Their issues should be identified and managed to
ensure the project is successful. Please state the key stakeholders and how they relate to the
project. You may have already identified the relevant stakeholders under section G (collaborators
and PPI). Please use this section to include those stakeholders you have not directly engaged in the
design, delivery or dissemination of the research.
M
Risk management (200-500 words)
Describe any risks to the project and how these will be identified and minimised.
6
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 5: ETHICAL APPROVAL AND RESEARCH GOVERNANCE
Research normally requires review by a Research Ethics Committee (REC), whereas audit and service
evaluations are expected as part of quality assurance and, as such, they are exempt from formal REC
approval. They should, however, still be conducted following the same principles of informing
participants and obtaining consent when appropriate.
All studies involving patients require ethical approval, which is monitored by the Health Research
Authority
Applicants should to seek guidance as to whether formal REC approval is needed.
Please identify potential ethical issues which may arise throughout the whole process of the project,
and explain how the design of the project takes them into account.
Please state whether this project will be submitted for ethical approval (for example, to NHS NRES or a
University research ethics committee). If not, please fully justify the reasons.
Researchers wishing to conduct research in the NHS (or Health and Social Care (HSC) in Northern
Ireland) must obtain NHS or HSC management permission (also referred to as R&D approval) for each
NHS/HSC research site. If your research involves undertaking the research on the premises of a NHS
organisation, with NHS patients or with NHS staff, then the local NHS R&D office should be consulted.
Relevant contact information can be found on the Health Research Authority website.
SECTION 6: FINANCE
Please outline the resources that are required for your proposed project, under the appropriate
headings (or state if not applicable).
Staff costs
If appropriate, please justify the cost of each individual involved in the project, and outline how their
costed time is related to their grade and salary. Please also outline how much (as a percentage) of their
time is required.
Please ensure that all staff costs include any salary increments due throughout the project duration.
Please do not include estimated increases for cost of living pay rises or ‘additional’ or ‘discretionary’
increment points above one salary increment per annum.
Full Economic Costing/overheads
Pharmacy Research UK is a member of the Association of Medical Research Charities and therefore only
funds direct clinical research costs, with infrastructure funded by the Department of Health under
AcoRD.
The UKCPA and Pharmacy Research UK are NIHR non-commercial partners. This means that the
research we fund can be adopted onto the NIHR portfolio and is entitled to NIHR Clinical Research
Network support. Therefore, we encourage applicants to involve the Clinical Research Networks (and
the local Research Design Service) in the development of their study, including the realistic costing of
the project.
Conference attendance
In addition to any other conferences you intend to attend, you must include here the costs of attending
one UKCPA conferences during the lifetime of the project.
7
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
Formal and informal training and support
Please include the costs of any formal training programmes, meetings with mentors and/or
organisations such as PRUK and the Royal Pharmaceutical Society for advice and support throughout the
project.
SECTION 7: DECLARATIONS
We require that the Lead Applicant provides a declaration from their department or organisation
confirming that the work can be accommodated in the department or organisation.
Please also ensure that signatures are received from the administering organisation’s finance
department and Head of Department. All applicants named on the proposal must also complete this
section.
GENERAL POINTS FOR COMPLETING THE FORM
1. Please ensure that all the pages are clearly numbered, this is especially important to check if you
have added in additional pages.
2. Please retain an electronic copy of the form that you submit.
3. All text (minimum font 10 points) must appear within the tables.
4. Please ensure that your two hard copies are collated correctly, double sided and stapled (please do
not bind).
5. Please ensure that your proposal complies with the Research Governance Framework, which can be
found on the Department of Health’s website here:
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/139565/dh_4122
427.pdf
6. As we will not accept late applications it is important that you make appropriate arrangements to
ensure that the necessary documents arrive in our office prior to the closing date and time. It is
advisable to have the documents delivered by a ‘guaranteed delivery time’ prior to the closing date
and time.
7. Please allow sufficient time to obtain the necessary signatures.
SUBMITTING YOUR PROPOSAL
Applicants are asked to submit full proposals (one electronic copy and two hard copies) to the address
below:
Clinical Pharmacy Research Grant
Pharmacy Research UK
66-68 East Smithfield
London E1W 1AW
Tel:
020 7572 2275
Email: Practice.Research@rpharms.com
TWO HARD COPIES (double sided) of the proposal should be submitted (minimum font 10pt).
Please note we will not accept faxed submissions or hand written proposals.
Please clearly label the outside of the envelope in which you submit your proposal with the following:
‘UKCPA- Pharmacy Research UK Clinical Pharmacy Research Grant Application’. This will enable us to
8
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
identify proposals and keep them aside so that they may all be opened together after the closing date
and time.
Please note that for administrative purposes, relating to this call for proposals, we have placed your
contact details on our internal database. On occasions beyond the scope of this call, we may wish to
contact you regarding research matters. If you do not wish to remain on our database for these
purposes please tick here.
9
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 1: RESEARCH PROPOSAL OUTLINE
Full Title of the Project
Proposed Duration
(months)
Proposed Start Date
Total Cost
£
Please suggest three people who we might approach to peer review your proposal – it is possible that we
will use one of these people and/or two from our database. Please include their area of expertise and
full contact details including email.
1.
2.
3.
Lead applicant details (to whom all correspondence will be addressed)
Name
Title
First name
Last name
First name
Last name
Post Held
Organisation
Address
Postcode
Tel. No.
Fax No.
Email
Number of
additional
applicants
Co-Lead applicant details (if applicable)
Name
Title
Post Held
Organisation
Address
Postcode
Email
Tel
Fax
10
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
Other applicant details (please add additional pages if necessary)
Name
Title
First name
Last name
Tel
Fax
Post Held
Organisation
Address
Postcode
Email
Other applicant details (please add additional pages if necessary)
Name
Title
First name
Last name
Tel
Fax
Post Held
Organisation
Address
Postcode
Email
Other applicant details (please add additional pages if necessary)
Name
Title
First name
Last name
Tel
Fax
Post Held
Organisation
Address
Postcode
Email
Other applicant details (please add additional pages if necessary)
Name
Title
First name
Last name
Tel
Fax
Post Held
Organisation
Address
Postcode
Email
Please also attach a brief Curriculum Vitae for all applicants (maximum of two sides of A4) at the end of
the application.
1
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 2: TECHNICAL SUMMARY OF THE PROPOSAL
Technical summary of the research proposal (to be published if application is successful) – Max 500
words
2
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 3: LAY SUMMARY OF THE PROPOSAL
Lay summary of the research proposal (to be published if application is successful) – Max 500 words
3
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 4: DETAILS OF THE RESEARCH PROPOSAL
A
Aims and objectives (200 words)
B
Relevance to UKCPA vision and Pharmacy Research UK vision and purpose (500 words)
C
Benefits of the proposed research (800 words)
D
Background (1,500 words)
E
Plan of investigation (1,750 words)
F
List of outputs/deliverables and plans for dissemination (500 words)
4
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
G
Study management (800 words)
H
Development of research skills (500 words)
I
Project timetable (500 words)
J
Measures of success (500 words)
K
Future plans (500 words)
L
Stakeholders (200-500 words)
5
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
M
Risk management (200-500 words)
6
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 5: ETHICAL APPROVAL AND RESEARCH GOVERNANCE
Please identify potential ethical issues which may arise throughout the whole process of the project,
and explain how the design of the project takes them into account.
Is ethical approval required for this project? If no, please justify.
Is NHS or HSC management permission required (also referred to as R&D approval)? If no, please
justify.
7
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 6: FINANCE
Please list requested financial support under the headings below.
CLINICAL RESEARCH COSTS
Details, if appropriate
Staff/human resources
(Please list title, grade, salary,
Superannuation and National
Insurance, and indicate
whether/when an increment would
come into effect for each staff
member involved in the research
and how much (as a percentage) of
their time is required.
Travel and subsistence
Project costs [e.g. meetings,
equipment, software, training
programme attendance,
postage, publications,
conference attendance].
NB. You must include here the
cost of attendance at one UKCPA
conference to report your
findings.
Formal and informal training and
support costs not included
elsewhere
Other (please provide details)
TOTAL
8
Cost
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
SECTION 7: DECLARATIONS
FOR THE HEAD OF DEPARTMENT OR ORGANISATION:
I declare that I have read this application and that, if funded, the work will be accommodated and
administered in the department / organisation and that the applicants for whom we are responsible may
undertake this work.
Signature
Date
Name (BLOCK CAPITALS)
Post Held
Organisation
Address
Postcode
Tel. No.
Fax No.
Email
FOR THE ADMINISTERING ORGANISATION’S FINANCE DEPARTMENT, to be signed by finance officer or
equivalent:
I declare that the financial information given on this form is complete and correct and agree to administer the
award, if made. The staff grades and salaries quoted are correct and in accordance with the normal practice
of this organisation.
Signature
Date
Name (BLOCK CAPITALS)
Post Held
Organisation
Address
Postcode
Tel. No.
Fax No.
Email
9
UKCPA Pharmacy Research UK Clinical Pharmacy Research Grant: Application form
Last updated: December 2015
FOR LEAD APPLICANT ONLY:
I declare that I will be actively engaged in, and in day to day control of the project.
Signature
Date
Name (BLOCK CAPITALS)
FOR ALL APPLICANTS: (please add additional pages if necessary)
I declare that the information given on this form is complete and correct.
Signature
Date
Name (BLOCK CAPITALS)
Signature
Date
Name (BLOCK CAPITALS)
Signature
Date
Name (BLOCK CAPITALS)
10